( ($TSE:KSI) ) has provided an announcement. Kneat.com has signed a Services Agreement with a major multinational generic ...

LIMERICK, Ireland, April 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. KSIOF's gross margins have expanded to 75% by 2024, nearing EBITDA profitability ...

The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device ...

LIMERICK, Ireland, April 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a ...

(MENAFN- GlobeNewsWire - Nasdaq) LIMERICK, Ireland, April 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and ...